ACOLTREMON

ACOLTREMON was reported 6335 times

ACOLTREMON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRIGEMINAL NERVE STIMULATION 2 0.6667
1 PINGUECULITIS 1 0.1667
2 SCLERAL GRAFT 1 0.1429
3 INSTILLATION SITE COLDNESS 1 0.1429
4 ADMINISTRATION SITE PUSTULE 1 0.1111
5 NERVE GRAFT 1 0.0909
6 EYELID DISCOLOURATION 4 0.0784
7 EYE IRRITATION 3268 0.0567
8 THERMAL BURNS OF EYE 12 0.0531
9 TRIGEMINAL NEUROPATHY 1 0.0455
10 ADMINISTRATION SITE SCAB 1 0.0385
11 COLD BURN 1 0.0357
12 KALEIDOSCOPE VISION 1 0.0312
13 PERIORBITAL DISCOMFORT 2 0.0312
14 EYE PROSTHESIS INSERTION 1 0.0256
15 TRIGEMINO-CARDIAC REFLEX 2 0.0247
16 OCULAR DISCOMFORT 260 0.0231
17 EYE PAIN 1110 0.0197
18 SWOLLEN TEAR DUCT 2 0.0189
19 EYE ABRASION 1 0.0189
20 NEUROTROPHIC KERATOPATHY 1 0.0185
21 MULTIPLE USE OF SINGLE-USE PRODUCT 96 0.0171
22 DENTAL PARAESTHESIA 1 0.0164
23 PUNCTAL PLUG INSERTION 1 0.0143
24 TYMPANIC MEMBRANE HYPERAEMIA 1 0.0141
25 ABNORMAL SENSATION IN EYE 60 0.0139
26 PERIORBITAL INFLAMMATION 3 0.0130
27 LACRIMATION DECREASED 6 0.0126
28 DRY EYE 604 0.0121
29 SUPERFICIAL INJURY OF EYE 13 0.0119
30 EYELID IRRITATION 29 0.0115
31 EYELID EROSION 1 0.0115
32 FOREIGN BODY SENSATION IN EYES 71 0.0111
33 OCULAR HYPERAEMIA 489 0.0103
34 TYPICAL AURA WITHOUT HEADACHE 1 0.0102
35 PERIORBITAL SWELLING 54 0.0095
36 LACRIMATION INCREASED 280 0.0093
37 EYELID RASH 9 0.0092
38 KERATORHEXIS 1 0.0088
39 PERIORBITAL IRRITATION 3 0.0088
40 TRIGEMINAL NERVE DISORDER 3 0.0086
41 SWELLING OF EYELID 52 0.0083
42 BLEPHAROPLASTY 1 0.0082
43 CONJUNCTIVAL DISCOLOURATION 1 0.0082
44 SKIN LESION INFLAMMATION 1 0.0076
45 ERYTHEMA OF EYELID 40 0.0074
46 ADMINISTRATION SITE IRRITATION 1 0.0071
47 EYE DISCHARGE 74 0.0071
48 PERIORBITAL PAIN 6 0.0071
49 EYELID MARGIN CRUSTING 20 0.0069
50 FACIAL NERVE DISORDER 3 0.0068
51 HYPOAESTHESIA EYE 4 0.0068
52 EYE PARAESTHESIA 1 0.0064
53 EYE PRURITUS 203 0.0060
54 DOSING ERROR 1 0.0060
55 PRODUCT AFTER TASTE 5 0.0052
56 OPHTHALMIC HERPES SIMPLEX 3 0.0052
57 VISUAL BRIGHTNESS 2 0.0051
58 IRREGULAR SLEEP WAKE RHYTHM DISORDER 1 0.0050
59 OCULAR ROSACEA 1 0.0049
60 EYELIDS PRURITUS 15 0.0048
61 CORNEAL GRAFT REJECTION 1 0.0048
62 EXCESSIVE EYE BLINKING 7 0.0047
63 CHALAZION 3 0.0047
64 PATIENT DISSATISFACTION WITH TREATMENT 9 0.0047
65 PRODUCT INTOLERANCE 1 0.0045
66 EYELID PAIN 9 0.0044
67 ASTHENOPIA 24 0.0044
68 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
69 FACIAL DISCOMFORT 3 0.0042
70 PRODUCT DESIGN ISSUE 3 0.0042
71 PALATAL SWELLING 1 0.0041
72 CORNEAL NEOVASCULARISATION 1 0.0040
73 PARANASAL SINUS HYPOSECRETION 1 0.0040
74 BLEPHARITIS 16 0.0040
75 BURNING FEET SYNDROME 1 0.0040
76 EYE INFLAMMATION 38 0.0040
77 PATIENT DISSATISFACTION WITH DEVICE 1 0.0040
78 EYELID OPERATION 1 0.0037
79 VISION BLURRED 511 0.0037
80 HORDEOLUM 16 0.0037
81 EYE SWELLING 133 0.0036
82 BURNING MOUTH SYNDROME 2 0.0035
83 LENS DISORDER 1 0.0035
84 LACRIMAL DISORDER 2 0.0034
85 BLOOD OESTROGEN INCREASED 2 0.0034
86 INCREASED DOSE ADMINISTERED 1 0.0032
87 TRICHIASIS 1 0.0031
88 PACKAGING DESIGN ISSUE 1 0.0030
89 PHOTOPHOBIA 55 0.0029
90 CORNEAL ABRASION 4 0.0029
91 OPHTHALMIC MIGRAINE 2 0.0029
92 EYE SYMPTOM 1 0.0028
93 XANTHOPSIA 1 0.0027
94 NASAL TURBINATE HYPERTROPHY 1 0.0027
95 ANISOCORIA 1 0.0026
96 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
97 EYELID EXFOLIATION 2 0.0025
98 EYELID SKIN DRYNESS 3 0.0025
99 DRUG WITHDRAWAL HEADACHE 1 0.0024
100 EXPOSURE VIA EYE CONTACT 1 0.0024
101 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
102 TONGUE PRURITUS 2 0.0023
103 DACRYOSTENOSIS ACQUIRED 3 0.0023
104 CORNEAL DISORDER 5 0.0023
105 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0022
106 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
107 DRUG EFFECT LESS THAN EXPECTED 32 0.0022
108 BLEPHAROSPASM 13 0.0021
109 PHOTOPSIA 13 0.0021
110 INTRAOCULAR LENS IMPLANT 1 0.0020
111 EYE INJURY 6 0.0020
112 INJURY CORNEAL 1 0.0019
113 HYPERMETABOLISM 1 0.0019
114 PHARYNGEAL MASS 1 0.0019
115 ADVERSE REACTION 25 0.0019
116 EYE INFECTION 21 0.0019
117 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
118 CORNEAL EROSION 1 0.0019
119 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
120 PRODUCT CLOSURE ISSUE 1 0.0018
121 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
122 ADMINISTRATION SITE PAIN 2 0.0017
123 EYE OPERATION 8 0.0017
124 EYELID DISORDER 4 0.0017
125 VITREOUS FLOATERS 17 0.0017
126 OPTIC NERVE INJURY 2 0.0017
127 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
128 AMBLYOPIA 1 0.0017
129 KERATITIS 5 0.0016
130 NASAL DISCOMFORT 13 0.0016
131 RETINAL TEAR 4 0.0016
132 PRODUCT TEMPERATURE EXCURSION ISSUE 8 0.0016
133 MOTION SICKNESS 3 0.0016
134 ALLERGIC OEDEMA 1 0.0015
135 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
136 OFF LABEL USE OF DEVICE 2 0.0015
137 THYROXINE INCREASED 1 0.0014
138 GLASSY EYES 1 0.0014
139 EAR DISCOMFORT 14 0.0014
140 STRABISMUS 4 0.0014
141 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
142 EYE DISORDER 44 0.0013
143 TENDON DISCOMFORT 1 0.0013
144 EYE HAEMORRHAGE 17 0.0013
145 RHINORRHOEA 81 0.0013
146 LIP ERYTHEMA 1 0.0013
147 NIGHT BLINDNESS 2 0.0012
148 INSTILLATION SITE PAIN 3 0.0012
149 MEDICAL PROCEDURE 2 0.0012
150 DENTAL DISCOMFORT 1 0.0012
151 EYELID PTOSIS 12 0.0012
152 MYCOTIC ALLERGY 1 0.0012
153 VISUAL IMPAIRMENT 143 0.0012
154 EAR PRURITUS 4 0.0011
155 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
156 PUNCTATE KERATITIS 1 0.0011
157 METAMORPHOPSIA 2 0.0011
158 BURNING SENSATION 74 0.0011
159 DRUG INEFFECTIVE 1382 0.0010
160 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
161 FOREIGN BODY IN EYE 1 0.0010
162 CATARACT OPERATION 6 0.0010
163 OROPHARYNGEAL DISCOMFORT 9 0.0010
164 TRIGEMINAL NEURALGIA 4 0.0010
165 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
166 ALLERGY TO ANIMAL 1 0.0009
167 ORCHITIS 1 0.0009
168 PHARYNGEAL SWELLING 9 0.0009
169 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
170 MADAROSIS 10 0.0009
171 SINUS PAIN 2 0.0009
172 ALLODYNIA 1 0.0009
173 LIP ULCERATION 1 0.0009
174 INSTILLATION SITE IRRITATION 1 0.0008
175 CONJUNCTIVAL HYPERAEMIA 3 0.0008
176 MYOPIA 2 0.0008
177 SINUS OPERATION 2 0.0008
178 PRODUCT USE COMPLAINT 13 0.0008
179 PRODUCT CONTAINER ISSUE 7 0.0008
180 SINUS DISORDER 16 0.0008
181 NASAL PRURITUS 1 0.0008
182 FACIAL PAIN 7 0.0008
183 INTRAOCULAR PRESSURE INCREASED 10 0.0008
184 HERPES OPHTHALMIC 1 0.0008
185 LIP EXFOLIATION 1 0.0008
186 INTENSIVE CARE 1 0.0007
187 CONJUNCTIVITIS 13 0.0007
188 OCULAR ICTERUS 3 0.0007
189 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
190 DARK CIRCLES UNDER EYES 1 0.0007
191 EYE ALLERGY 1 0.0006
192 VASCULAR RUPTURE 1 0.0006
193 ROSACEA 3 0.0006
194 OPHTHALMOPLEGIA 1 0.0006
195 NASAL ULCER 1 0.0006
196 CONDITION AGGRAVATED 190 0.0006
197 MILIARIA 1 0.0006
198 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102 0.0006
199 SKIN HYPOPIGMENTATION 1 0.0006
200 PRODUCT DELIVERY MECHANISM ISSUE 3 0.0006
201 OPHTHALMIC HERPES ZOSTER 1 0.0006
202 BLINDNESS TRANSIENT 4 0.0005
203 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
204 SNEEZING 12 0.0005
205 TUNNEL VISION 1 0.0005
206 NASAL OBSTRUCTION 1 0.0005
207 PRODUCT STORAGE ISSUE 2 0.0005
208 PARANASAL SINUS HYPERSECRETION 2 0.0005
209 RETINAL OEDEMA 1 0.0005
210 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
211 SINUS HEADACHE 3 0.0005
212 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
213 NASAL DRYNESS 3 0.0005
214 OPTIC NEUROPATHY 1 0.0005
215 EAR SWELLING 1 0.0005
216 PRODUCT DISPENSING ISSUE 2 0.0005
217 CORNEAL OEDEMA 1 0.0004
218 PRODUCT LABEL ISSUE 3 0.0004
219 EYE MOVEMENT DISORDER 3 0.0004
220 READING DISORDER 1 0.0004
221 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
222 THERMAL BURN 3 0.0004
223 PRODUCT PACKAGING ISSUE 4 0.0004
224 PRODUCT PACKAGING CONFUSION 1 0.0004
225 INCORRECT DOSAGE ADMINISTERED 2 0.0004
226 APPLICATION SITE BURN 2 0.0004
227 SECRETION DISCHARGE 5 0.0004
228 DRUG TOLERANCE 2 0.0004
229 HYPERSENSITIVITY 73 0.0004
230 NASAL CONGESTION 23 0.0004
231 INCREASED UPPER AIRWAY SECRETION 2 0.0004
232 PRODUCT RESIDUE PRESENT 2 0.0004
233 SKIN DISCOMFORT 1 0.0004
234 SINUS CONGESTION 5 0.0004
235 EAR CONGESTION 1 0.0004
236 ULCERATIVE KERATITIS 1 0.0004
237 RHINALGIA 1 0.0004
238 MIGRAINE 34 0.0004
239 NECK MASS 1 0.0004
240 PRODUCT USE ISSUE 66 0.0004
241 SKIN SWELLING 3 0.0003
242 PRODUCT LABEL CONFUSION 2 0.0003
243 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
244 HEAD DISCOMFORT 6 0.0003
245 DISCOMFORT 20 0.0003
246 SKIN EROSION 1 0.0003
247 CARDIAC FLUTTER 2 0.0003
248 HEADACHE 186 0.0003
249 TONGUE ULCERATION 1 0.0003
250 FACIAL PARESIS 1 0.0003
251 RETCHING 6 0.0003
252 SKIN WEEPING 1 0.0003
253 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
254 INTENTIONAL UNDERDOSE 2 0.0003
255 BLINDNESS 11 0.0003
256 PARANASAL SINUS DISCOMFORT 1 0.0003
257 DERMATITIS CONTACT 3 0.0003
258 PANIC DISORDER 1 0.0003
259 BRAIN FOG 4 0.0003
260 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
261 PHOTOSENSITIVITY REACTION 4 0.0002
262 LIP SWELLING 8 0.0002
263 TONGUE DISCOMFORT 1 0.0002
264 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
265 PURULENT DISCHARGE 1 0.0002
266 MYDRIASIS 3 0.0002
267 TEARFULNESS 1 0.0002
268 DIPLOPIA 6 0.0002
269 CHAPPED LIPS 1 0.0002
270 TONGUE DISCOLOURATION 1 0.0002
271 EAR DISORDER 1 0.0002
272 YELLOW SKIN 1 0.0002
273 SKIN TIGHTNESS 1 0.0002
274 LIMB OPERATION 1 0.0002
275 PARAESTHESIA ORAL 3 0.0002
276 ADVERSE DRUG REACTION 18 0.0002
277 HYPOAESTHESIA ORAL 3 0.0002
278 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
279 ADVERSE EVENT 18 0.0002
280 PRODUCT STORAGE ERROR 17 0.0002
281 PERIORBITAL OEDEMA 1 0.0002
282 NYSTAGMUS 1 0.0002
283 SURGERY 11 0.0002
284 DIZZINESS 93 0.0002
285 SKIN BURNING SENSATION 13 0.0002
286 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
287 MACULAR OEDEMA 1 0.0002
288 THROAT IRRITATION 8 0.0002
289 SCAB 2 0.0002
290 MUSCLE TWITCHING 4 0.0002
291 URTICARIA 29 0.0002
292 UNEVALUABLE EVENT 13 0.0002
293 PALPITATIONS 20 0.0002
294 DECREASED INTEREST 1 0.0002
295 ODYNOPHAGIA 1 0.0002
296 MACULAR DEGENERATION 2 0.0002
297 DRUG INTOLERANCE 16 0.0002
298 ERYTHEMA 34 0.0002
299 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
300 SWOLLEN TONGUE 5 0.0002
301 ILLNESS 16 0.0002
302 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
303 HERPES SIMPLEX 1 0.0002
304 DEAFNESS 4 0.0002
305 OROPHARYNGEAL PAIN 14 0.0002
306 SKIN MASS 1 0.0001
307 PRODUCT ADMINISTRATION ERROR 3 0.0001
308 EXTRA DOSE ADMINISTERED 6 0.0001
309 DYSGEUSIA 11 0.0001
310 WRONG PRODUCT ADMINISTERED 1 0.0001
311 APHONIA 2 0.0001
312 DERMATITIS 3 0.0001
313 PAPULE 1 0.0001
314 RETINAL HAEMORRHAGE 1 0.0001
315 VISUAL FIELD DEFECT 1 0.0001
316 SWELLING FACE 9 0.0001
317 TONGUE DISORDER 1 0.0001
318 MAJOR DEPRESSION 1 0.0001
319 SENSITIVE SKIN 1 0.0001
320 GLOSSODYNIA 3 0.0001
321 ORAL PAIN 3 0.0001
322 EPISTAXIS 10 0.0001
323 GENERAL SYMPTOM 1 0.0001
324 PRODUCT DOSE OMISSION ISSUE 39 0.0001
325 CONCUSSION 1 0.0001
326 MULTIPLE ALLERGIES 1 0.0001
327 ATRIAL FLUTTER 1 0.0001
328 SENSORY DISTURBANCE 2 0.0001
329 RHINITIS 1 0.0001
330 RASH 54 0.0001
331 DRY MOUTH 10 0.0001
332 PRURITUS 47 0.0001
333 VISUAL ACUITY REDUCED 4 0.0001
334 SENSATION OF FOREIGN BODY 1 0.0001
335 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
336 CARDIAC OPERATION 1 0.0001
337 VERTIGO 7 0.0001
338 RESPIRATORY RATE INCREASED 1 0.0001
339 THROAT TIGHTNESS 3 0.0001
340 RASH PRURITIC 6 0.0001
341 LIP DRY 1 0.0001
342 TREATMENT NONCOMPLIANCE 6 0.0001
343 SKIN IRRITATION 5 0.0001
344 PRODUCT DISTRIBUTION ISSUE 1 0.0001
345 FEELING COLD 3 0.0001
346 THINKING ABNORMAL 2 0.0001
347 SKIN EXFOLIATION 9 0.0001
348 SLEEP APNOEA SYNDROME 2 0.0001
349 BALANCE DISORDER 9 0.0001
350 DIZZINESS POSTURAL 1 0.0001
351 CHOKING 2 0.0001
352 ORAL HERPES 2 0.0001
353 INCORRECT DOSE ADMINISTERED 23 0.0001
354 UPPER LIMB FRACTURE 2 0.0001
355 PRESCRIBED UNDERDOSE 2 0.0001
356 SALIVARY HYPERSECRETION 1 0.0001
357 TASTE DISORDER 2 0.0001
358 DRY THROAT 1 0.0001
359 SLUGGISHNESS 1 0.0001
360 TENDERNESS 1 0.0001
361 PRODUCT ODOUR ABNORMAL 1 0.0001
362 HALLUCINATION, VISUAL 2 0.0001
363 JOINT DISLOCATION 1 0.0001
364 DECREASED ACTIVITY 1 0.0001
365 FAECES DISCOLOURED 2 0.0001
366 ASPIRATION 1 0.0001
367 TOOTH DISORDER 2 0.0001
368 HYPERTENSIVE CRISIS 1 0.0001
369 RASH PAPULAR 2 0.0001
370 BLISTER 5 0.0001
371 IMPAIRED DRIVING ABILITY 1 0.0001
372 TINNITUS 4 0.0001
373 LETHARGY 5 0.0001
374 EYELID OEDEMA 1 0.0001
375 RASH MACULAR 3 0.0001
376 HOSPITALISATION 13 0.0001
377 HYPERLIPIDAEMIA 1 0.0001
378 RASH ERYTHEMATOUS 4 0.0001
379 PARAESTHESIA 13 0.0001
380 CRYING 3 0.0001
381 NEURALGIA 2 0.0001
382 SPINAL OPERATION 1 0.0001
383 PHARYNGITIS 1 0.0001
384 APPLICATION SITE IRRITATION 1 0.0001
385 SINUSITIS 8 0.0001
386 DISORIENTATION 3 0.0001
387 DRY SKIN 10 0.0001
388 SWELLING 7 0.0001
389 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
390 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
391 ORAL DISCOMFORT 1 0.0001
392 HAEMOPTYSIS 2 0.0001
393 MASS 1 0.0001
394 SEASONAL ALLERGY 1 0.0001
395 PAIN IN JAW 2 0.0001
396 THERAPY INTERRUPTED 5 0.0001
397 ANOSMIA 1 0.0001
398 SKIN HAEMORRHAGE 1 0.0001
399 CATARACT 4 0.0001
400 HYPOAESTHESIA 10 0.0001
401 INSURANCE ISSUE 1 0.0001
402 THERAPY PARTIAL RESPONDER 1 0.0001
403 DYSPNOEA 36 0.0001
404 CYANOSIS 1 0.0001
405 PAIN 39 0.0001
406 ULCER 1 0.0001
407 MANIA 1 0.0001
408 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
409 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
410 SCAR 1 0.0001
411 MUSCULOSKELETAL DISCOMFORT 1 0.0001
412 NERVOUSNESS 3 0.0001
413 SPEECH DISORDER 3 0.0001
414 DEVICE USE ISSUE 1 0.0001
415 SLEEP DISORDER 4 0.0001
416 TOOTHACHE 1 0.0001
417 PELVIC PAIN 1 0.0001
418 RESTLESS LEGS SYNDROME 1 0.0001
419 ACCIDENTAL OVERDOSE 2 0.0001
420 HEPATIC STEATOSIS 1 0.0001
421 NAUSEA 42 0.0001
422 FEELING JITTERY 1 0.0001
423 INCREASED APPETITE 1 0.0001
424 ERUCTATION 1 0.0001
425 DYSPHONIA 3 0.0001
426 SKIN FISSURES 1 0.0001
427 SPINAL FRACTURE 1 0.0000
428 IRRITABILITY 3 0.0000
429 FEEDING DISORDER 1 0.0000
430 BODY TEMPERATURE INCREASED 1 0.0000
431 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
432 MALAISE 21 0.0000
433 OFF LABEL USE 41 0.0000
434 INTENTIONAL OVERDOSE 3 0.0000
435 POOR QUALITY SLEEP 1 0.0000
436 FEELING ABNORMAL 11 0.0000
437 PRODUCT PRESCRIBING ISSUE 1 0.0000
438 INTENTIONAL PRODUCT MISUSE 4 0.0000
439 DEVICE DIFFICULT TO USE 3 0.0000
440 STEVENS-JOHNSON SYNDROME 1 0.0000
441 SOMNOLENCE 9 0.0000
442 CHROMATURIA 1 0.0000
443 SKIN DISCOLOURATION 2 0.0000
444 ARRHYTHMIA 2 0.0000
445 DYSPHAGIA 4 0.0000
446 BLOOD PRESSURE FLUCTUATION 1 0.0000
447 PRESYNCOPE 1 0.0000
448 PRODUCT COMPLAINT 1 0.0000
449 FLUSHING 4 0.0000
450 COUGH 11 0.0000
451 HYPOPHAGIA 1 0.0000
452 EXPOSURE VIA SKIN CONTACT 1 0.0000
453 ECZEMA 2 0.0000
454 APPLICATION SITE ERYTHEMA 1 0.0000
455 JOINT STIFFNESS 1 0.0000
456 NASOPHARYNGITIS 7 0.0000
457 INSOMNIA 10 0.0000
458 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
459 PAIN OF SKIN 1 0.0000
460 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
461 ABDOMINAL DISCOMFORT 6 0.0000
462 ASTHMA 4 0.0000
463 INTENTIONAL DOSE OMISSION 1 0.0000
464 ANGINA PECTORIS 1 0.0000
465 NEEDLE ISSUE 1 0.0000
466 URINARY INCONTINENCE 1 0.0000
467 WHEEZING 2 0.0000
468 GASTROINTESTINAL DISORDER 3 0.0000
469 BLOOD POTASSIUM DECREASED 1 0.0000
470 BLOOD PRESSURE INCREASED 5 0.0000
471 FEELING HOT 2 0.0000
472 LIMB DISCOMFORT 1 0.0000
473 CYSTITIS 1 0.0000
474 HYPOTHYROIDISM 1 0.0000
475 HYPERHIDROSIS 4 0.0000
476 NIGHT SWEATS 1 0.0000
477 HEART RATE INCREASED 3 0.0000
478 EXPIRED PRODUCT ADMINISTERED 1 0.0000
479 SKIN DISORDER 1 0.0000
480 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
481 MEMORY IMPAIRMENT 4 0.0000
482 INJURY 2 0.0000
483 HYPERTENSION 6 0.0000
484 LYMPHADENOPATHY 1 0.0000
485 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
486 INFECTION 4 0.0000
487 RESTLESSNESS 1 0.0000
488 BRONCHITIS 2 0.0000
489 INTESTINAL OBSTRUCTION 1 0.0000
490 DEATH 22 0.0000
491 DEVICE BREAKAGE 1 0.0000
492 ANXIETY 7 0.0000
493 INFLUENZA LIKE ILLNESS 2 0.0000
494 ABDOMINAL PAIN UPPER 5 0.0000
495 TREMOR 4 0.0000
496 ROAD TRAFFIC ACCIDENT 1 0.0000
497 WITHDRAWAL SYNDROME 1 0.0000
498 HYPOACUSIS 1 0.0000
499 MUSCULOSKELETAL STIFFNESS 2 0.0000
500 ANGIOEDEMA 1 0.0000
501 LIVER DISORDER 1 0.0000
502 TACHYCARDIA 2 0.0000
503 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
504 PRODUCT QUALITY ISSUE 3 0.0000
505 RENAL DISORDER 1 0.0000
506 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
508 FATIGUE 16 0.0000
509 LUNG DISORDER 1 0.0000
510 FLUID RETENTION 1 0.0000
511 CHEST DISCOMFORT 2 0.0000
512 THERAPY CESSATION 1 0.0000
513 INFLAMMATION 1 0.0000
514 DRUG INTERACTION 3 0.0000
515 ASTHENIA 7 0.0000
516 CONFUSIONAL STATE 3 0.0000
517 PNEUMONIA 6 0.0000
518 OEDEMA 1 0.0000
519 ARTHROPATHY 1 0.0000
520 INFLUENZA 2 0.0000
521 NECK PAIN 1 0.0000
522 OXYGEN SATURATION DECREASED 1 0.0000
523 FLATULENCE 1 0.0000
524 HERPES ZOSTER 1 0.0000
525 STOMATITIS 1 0.0000
526 ILL-DEFINED DISORDER 1 0.0000
527 MUSCLE SPASMS 3 0.0000
528 CHEST PAIN 3 0.0000
529 EXPOSURE DURING PREGNANCY 1 0.0000
530 DEEP VEIN THROMBOSIS 1 0.0000
531 FALL 5 0.0000
532 NEOPLASM MALIGNANT 1 0.0000
533 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
534 DEPRESSION 3 0.0000
535 PERIPHERAL SWELLING 2 0.0000
536 DRUG DOSE OMISSION BY DEVICE 1 0.0000
537 ARTHRITIS 1 0.0000
538 DIARRHOEA 8 0.0000
539 CEREBROVASCULAR ACCIDENT 2 0.0000
540 URINARY TRACT INFECTION 2 0.0000
541 MYOCARDIAL INFARCTION 2 0.0000
542 CARDIAC DISORDER 1 0.0000
543 CONTUSION 1 0.0000
544 ATRIAL FIBRILLATION 1 0.0000
545 DYSPEPSIA 1 0.0000
546 ABDOMINAL DISTENSION 1 0.0000
547 HAEMORRHAGE 1 0.0000
548 OVERDOSE 2 0.0000
549 CONSTIPATION 2 0.0000
550 SEPSIS 1 0.0000
551 BACK PAIN 2 0.0000
552 CHILLS 1 0.0000
553 VOMITING 4 0.0000
554 DISEASE PROGRESSION 1 0.0000
555 EMOTIONAL DISTRESS 1 0.0000
556 DEHYDRATION 1 0.0000
557 MYALGIA 1 0.0000
558 NO ADVERSE EVENT 1 0.0000
559 BLOOD GLUCOSE INCREASED 1 0.0000
560 ANAEMIA 1 0.0000
561 GAIT DISTURBANCE 1 0.0000
562 HYPOTENSION 1 0.0000
563 ARTHRALGIA 2 0.0000
564 WEIGHT INCREASED 1 0.0000
565 DECREASED APPETITE 1 0.0000
566 ABDOMINAL PAIN 1 0.0000
567 INJECTION SITE PAIN 1 0.0000